<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327610</url>
  </required_header>
  <id_info>
    <org_study_id>VHI1</org_study_id>
    <nct_id>NCT03327610</nct_id>
  </id_info>
  <brief_title>Selecting the Best Ventilator Hyperinflation Settings</brief_title>
  <acronym>VHI1</acronym>
  <official_title>Selecting the Best Ventilator Hyperinflation Settings Based on Physiologic Markers: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Universit치rio Augusto Motta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro Universit치rio Augusto Motta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator hyperinflation (VHI) has been shown to be effective in improving respiratory
      mechanics, secretion removal, and gas exchange in mechanically ventilated patients; however,
      there are no recommendations on the best ventilator settings to perform the technique. Thus,
      the aim of this study was to compare six modes of VHI, concerning physiological markers of
      efficacy and safety criteria, in order to support the optimal VHI settings selection for
      mechanically ventilated patients. In a randomized, controlled and crossover study, 30
      mechanically ventilated patients underwent 6 modes of ventilator hyperinflation. The maximum
      expansion (tidal volume), expiratory flow bias criteria (inspiratory and expiratory flow
      patterns), overdistension (alveolar pressure), asynchronies and hemodynamic variables (mean
      arterial pressure and heart rate) were assessed during the interventions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Ventilator Hyperinflation (VHI) has been shown to be effective in improving
      respiratory mechanics, secretion removal, and gas exchange in mechanically ventilated
      patients; however, there are no recommendations on the best ventilator settings to perform
      the technique. Thus, the aim of this study was to compare six modes of VHI, concerning
      physiological markers of efficacy and safety criteria, in order to support the optimal VHI
      settings selection for mechanically ventilated patients.

      Methods: In a crossover study, every included mechanically ventilated patient underwent six
      modes of VHI in a randomized order: Volume Control Continuous Mandatory Ventilation (VC-CMV)
      with inspiratory flow = 20Lpm (VC-CMV20), VC-CMV with inspiratory flow = 50Lpm (VC-CMV50),
      Pressure Control Continuous Mandatory Ventilation (PC-CMV) with inspiratory time = 1s.
      (PC-CMV1), PC-CMV with inspiratory time = 3s. (PC-CMV3), Pressure Support Ventilation (PSV)
      with cycling off = 10% of peak inspiratory flow (PSV10), and PSV with cycling off = 25% of
      peak inspiratory flow (PSV25). The maximum expansion (tidal volume), expiratory flow bias
      criteria (inspiratory and expiratory flow patterns), over-distension (alveolar pressure),
      asynchronies and hemodynamic variables (mean arterial pressure and heart rate) were assessed
      during the interventions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak inspiratory to expiratory flow ratio</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Dichotomous variable, defined as achieving a peak inspiratory flow rate (PIFR) less than 90% of the peak expiratory flow rate (PEFR)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak expiratory flow higher than 40 Lpm</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Dichotomous variable, defined as achieving a PEFR higher than 40 l/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference between peak inspiratory and expiratory flows.</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Dichotomous variable, defined as achieving a difference higher than 17Lpm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary expansion</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Percentage of tidal volume above the normal tidal volume (estimated as 6mL/kg).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Mean arterial pressure verified using the multi-parameter monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Ten minutes after the onset of intervention.</time_frame>
    <description>Heart rate verified using the multi-parameter monitor.</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Respiration Disorders</condition>
  <arm_group>
    <arm_group_label>BASELINE</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The subjects were kept in their current ventilatory mode.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VC-CMV20</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory flow of 20Lpm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VC-CMV50</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory flow of 50Lpm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PC-CMV1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Pressure Control Continuous Mandatory Ventilation (PC-CMV1) with an inspiratory time of 1 second.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PC-CMV3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Pressure Control Continuous Mandatory Ventilation (PC-CMV1) with an inspiratory time of 3 seconds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV10</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Pressure Support Ventilation (PSV) with a cycling off of 10% of peak inspiratory flow.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV25</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Pressure Support Ventilation (PSV) with a cycling off of 25% of peak inspiratory flow.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VC-CMV20</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow was set at 20Lpm and the tidal volume was increased in steps of 200mL until the peak airway pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>VC-CMV20</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VC-CMV50</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow was set at 50Lpm and the tidal volume was increased in steps of 200mL until the peak airway pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>VC-CMV50</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PC-CMV1</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Pressure Control Continuous Mandatory Ventilation (PC-CMV1). The inspiratory time was set at 1 second and the pressure control was increased until a peak pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>PC-CMV1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PC-CMV3</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Pressure Control Continuous Mandatory Ventilation (PC-CMV1). The inspiratory time was set at 3 seconds and the pressure control was increased until a peak pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>PC-CMV3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PSV10</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Pressure Support Ventilation (PSV). The cycling off was set at 10% of peak inspiratory flow and the pressure support was increased until a peak pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>PSV10</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PSV25</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Pressure Support Ventilation (PSV). The cycling off was set at 25% of peak inspiratory flow and the pressure support was increased until a peak pressure of 40cmH2O was achieved. After achieving the target pressure, this ventilatory regimen lasted 15 minutes. Positive end expiratory pressure and the inspired oxygen fraction were not modified.</description>
    <arm_group_label>PSV25</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients under mechanical ventilation for more than 48h

        Exclusion Criteria:

          -  mucus hypersecretion (defined as the need for suctioning &lt; 2-h intervals),

          -  absence of respiratory drive,

          -  atelectasis,

          -  severe bronchospasm,

          -  positive end expiratory pressure &gt; 10cmH2O,

          -  PaO2-FiO2 relationship &lt; 150,

          -  mean arterial pressure &lt; 60mmHg,

          -  inotrope requirement equivalent to &gt;15 ml/h total of adrenaline and noradrenalin,

          -  intracranial pressure &gt; 20mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>FERNANDO S GUIMARAES, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Centro Universit치rio Augusto Motta</affiliation>
  </overall_official>
  <link>
    <url>https://www.researchgate.net/profile/FERNANDO_GUIMARAES</url>
    <description>Researchgate profile (Chair researcher)</description>
  </link>
  <link>
    <url>http://www.researcherid.com/ProfileView.action?returnCode=ROUTER.Unauthorized&amp;Init=Yes&amp;SrcApp=CR&amp;queryString=KG0UuZjN5WkrS6qTMqySbml%252FKME%252FypfZgkjPia93VtU%253D</url>
    <description>ResearcherID profile (Chair researcher)</description>
  </link>
  <reference>
    <citation>Berney S, Denehy L. A comparison of the effects of manual and ventilator hyperinflation on static lung compliance and sputum production in intubated and ventilated intensive care patients. Physiother Res Int. 2002;7(2):100-8.</citation>
    <PMID>12109234</PMID>
  </reference>
  <reference>
    <citation>Lemes DA, Zin WA, Guimaraes FS. Hyperinflation using pressure support ventilation improves secretion clearance and respiratory mechanics in ventilated patients with pulmonary infection: a randomised crossover trial. Aust J Physiother. 2009;55(4):249-54.</citation>
    <PMID>19929767</PMID>
  </reference>
  <reference>
    <citation>Thomas PJ. The effect of mechanical ventilator settings during ventilator hyperinflation techniques: a bench-top analysis. Anaesth Intensive Care. 2015 Jan;43(1):81-7.</citation>
    <PMID>25579293</PMID>
  </reference>
  <reference>
    <citation>Ntoumenopoulos G, Shannon H, Main E. Do commonly used ventilator settings for mechanically ventilated adults have the potential to embed secretions or promote clearance? Respir Care. 2011 Dec;56(12):1887-92. doi: 10.4187/respcare.01229. Epub 2011 Jun 17.</citation>
    <PMID>21682986</PMID>
  </reference>
  <reference>
    <citation>Anderson A, Alexanders J, Sinani C, Hayes S, Fogarty M. Effects of ventilator vs manual hyperinflation in adults receiving mechanical ventilation: a systematic review of randomised clinical trials. Physiotherapy. 2015 Jun;101(2):103-10. doi: 10.1016/j.physio.2014.07.006. Epub 2014 Oct 6. Review.</citation>
    <PMID>25453540</PMID>
  </reference>
  <reference>
    <citation>Davies JD, Senussi MH, Mireles-Cabodevila E. Should A Tidal Volume of 6 mL/kg Be Used in All Patients? Respir Care. 2016 Jun;61(6):774-90. doi: 10.4187/respcare.04651. Review.</citation>
    <PMID>27235313</PMID>
  </reference>
  <reference>
    <citation>de Wit M. Monitoring of patient-ventilator interaction at the bedside. Respir Care. 2011 Jan;56(1):61-72. doi: 10.4187/respcare.01077.</citation>
    <PMID>21235839</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Universit치rio Augusto Motta</investigator_affiliation>
    <investigator_full_name>Fernando Silva Guimaraes</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Respiratory Therapy</keyword>
  <keyword>Positive Pressure Respiration</keyword>
  <keyword>Physical Therapy Modalities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

